ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Lipocine Receives FDA Clearance for Testing of NASH Candidate americanpharmaceuticalreview
July 25, 2019Lipocine has received clearance from the U.S. Food and Drug Administration (FDA) to clinically investigate LPCN 1144 in an expanded target population of adult male non-alcoholic steatohepatitis (NASH) patients.
Pharma Sources Insight January 2025
